Patent · US Active

Cinnamoyl-piperazine derivatives and their use as par-1 antagonists

US8513258B2 · kind B2 · utility

1Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2012
Grant dateAug 20, 2013
Priority date
Expiry dateMay 21, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of general formula (I): These compounds are useful as protease-activated receptor-1 (PAR-1) antagonists, particularly in the treatment of thrombosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.